Literature DB >> 17983446

Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

H E Baxendale1, M Johnson, R C M Stephens, J Yuste, N Klein, J S Brown, D Goldblatt.   

Abstract

The molecular and functional characteristics of natural antibody from the preimmune repertoire have not been explored in detail in man. We describe seven human IgM monoclonal antibodies selected on the basis of pneumococcal polysaccharide binding that share both molecular and functional characteristics with natural antibody, suggesting a common B cell lineage origin. Unlike class-switched antibodies, which are serotype-specific, the antibodies were polyreactive and bound all pneumococcal polysaccharide capsular serotypes tested. Some bound endogenous antigens, including blood group antigens and intermediate filament proteins. All the antibodies used unmutated heavy chain V (IGHV) that are expressed at an increased frequency in the elderly and in the preimmune repertoire. The CDR3 was characterized by long length (mean aa 18.4 (+/-4.2) and selective use of IGHD6 (P < 0.001) and IGHJ6 (P < 0.01) family genes. The clones expressing IGHV1-69 and IGHV 3-21 provided significant passive protection against invasive pneumococcal disease in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17983446      PMCID: PMC2276916          DOI: 10.1111/j.1365-2249.2007.03535.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  61 in total

1.  Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation.

Authors:  K E Elagib; M Børretzen; R Jonsson; H J Haga; J Thoen; K M Thompson; J B Natvig
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis.

Authors:  Véronique Giudicelli; Denys Chaume; Marie-Paule Lefranc
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  Identification of a B-1 B cell-specified progenitor.

Authors:  Encarnacion Montecino-Rodriguez; Hyosuk Leathers; Kenneth Dorshkind
Journal:  Nat Immunol       Date:  2006-01-22       Impact factor: 25.606

Review 4.  Signalling pathways in B cells: implications for autoimmunity.

Authors:  T Dörner; P E Lipsky
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

5.  VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection.

Authors:  E W Schettino; S K Chai; M T Kasaian; H W Schroeder; P Casali
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

6.  Requirements for mIgM-triggered activation versus apoptosis in human B cells.

Authors:  P Mongini; P Highet; J Inman
Journal:  Ann N Y Acad Sci       Date:  1997-04-05       Impact factor: 5.691

7.  Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM.

Authors:  Nicole Baker; Michael R Ehrenstein
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

Review 8.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

9.  Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Anastasia Hadzidimitriou; Tatjana Smilevska; Evangelia Kalagiakou; Katerina Hatzi; Niki Stavroyianni; Anastasia Athanasiadou; Aliki Tsompanakou; Theodora Papadaki; Garyfallia Kokkini; George Paterakis; Riad Saloum; Nikolaos Laoutaris; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

10.  Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates.

Authors:  R Rieben; E Y Korchagina; N V Bovin; M R Daha
Journal:  Transfus Clin Biol       Date:  1997       Impact factor: 1.406

View more
  29 in total

Review 1.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

2.  Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Authors:  Saeyoung Park; Moon H Nahm
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation.

Authors:  Peter I Lobo; Kailo H Schlegel; Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Binru Wang; Hong Ye; Thomas F Tedder; Gilbert R Kinsey; Mark D Okusa
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

Review 4.  Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Authors:  Trisha A Rettig; Julie N Harbin; Adelaide Harrington; Leonie Dohmen; Sherry D Fleming
Journal:  Clin Immunol       Date:  2015-07-02       Impact factor: 3.969

5.  IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection.

Authors:  Rachael Racine; Maura McLaughlin; Derek D Jones; Susan T Wittmer; Katherine C MacNamara; David L Woodland; Gary M Winslow
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

6.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.

Authors:  Katie J Doores; Michael Huber; Khoa M Le; Sheng-Kai Wang; Colleen Doyle-Cooper; Anthony Cooper; Ralph Pantophlet; Chi-Huey Wong; David Nemazee; Dennis R Burton
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

8.  Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups.

Authors:  Saeyoung Park; Archana R Parameswar; Alexei V Demchenko; Moon H Nahm
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

9.  Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.

Authors:  Ann-Charlotte Bergh; Chamilly Evaldsson; Lone Bredo Pedersen; Christian Geisler; Kostas Stamatopoulos; Richard Rosenquist; Anders Rosén
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

10.  Glucose impairs B-1 cell function in diabetes.

Authors:  K Jennbacken; S Ståhlman; L Grahnemo; O Wiklund; L Fogelstrand
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.